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Abstract
Liver transplants have their highest technical failure rate in the first two weeks following surgery. Currently, there are limited
devices for continuous, real-time monitoring of the graft. In this work, a three wavelengths system is presented that
combines near-infrared spectroscopy and photoplethysmography with a processing method that can uniquely measure
and separate the venous and arterial oxygen contributions. This strategy allows for the quantification of tissue oxygen
consumption used to study hepatic metabolic activity and to relate it to tissue stress. The sensor is battery operated and
communicates wirelessly with a data acquisition computer which provides the possibility of implantation provided
sufficient miniaturization. In two in vivo porcine studies, the sensor tracked perfusion changes in hepatic tissue during
vascular occlusions with a root mean square error (RMSE) of 0.135 mL/min/g of tissue. We show the possibility of using the
pulsatile wave to measure the arterial oxygen saturation similar to pulse oximetry. The signal is also used to extract the
venous oxygen saturation from the direct current (DC) levels. Arterial and venous oxygen saturation changes were
measured with an RMSE of 2.19% and 1.39% respectively when no vascular occlusions were induced. This error increased to
2.82% and 3.83% when vascular occlusions were induced during hypoxia. These errors are similar to the resolution of a
commercial oximetry catheter used as a reference. This work is the first realization of a wireless optical sensor for continuous
monitoring of hepatic hemodynamics.
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Introduction
Since the first successful liver transplant in 1963 [1], this
operation has become a standard treatment for end-stage liver
disease and acute liver failure. According to the Organ Procure-
ment and Transplantation Network (OPTN) annual report,
28,052 transplants were performed in 2012 and the one year
survival rate of the graft was approximately 82% and for the
patient 86.5% [2]. The first two weeks post-surgery are associated
with the highest technical failure rate [3]. The current standard of
care in that period relies on daily blood work and needle biopsies
for suspicious results [4]. These tests do not allow timely
intervention, and complications are often detected after substantial
damage is done to the graft, typically necessitating a second
surgery including re-transplantation. Clinical studies by various
groups have shown the possibility of using perfusion and/or
oxygen consumption as predictors of hepatic graft function post-
transplant [5–7]. Our group has developed an implantable
telemetry system to monitor both tissue perfusion and oxygenation
in the parenchyma of the liver which can be used to quantify stress
on the tissue related to vascular complications. Detection of such
complications at an early stage should allow for timely medical
intervention [8–11]. With minor adjustments to the hardware, the
principle of this sensor can potentially be applied to other tissue
models [12]. Figure 1 shows a schematic of the envisioned sensor.
Our continuous perfusion and oxygen consumption monitoring
system is a novel combination of photoplethysmography (PPG)
and Near Infrared Spectroscopy (NIRS). It employs Light
Emitting Diodes (LEDs) at three wavelengths of light in the near
infrared range (735, 805 and 940 nm). The LEDs are time
multiplexed, and a single photodetector is used to collect the
diffuse reflectance at each of the wavelengths [11]. Because of the
pulsatile nature of the arterial blood flow which causes periodic
fluctuations in the blood volume contained in the probed tissue,
the collected signal has a pulsatile component transduced as an
alternating current (AC) by the photodetector and can be used to
assess changes in the arterial blood supplying the tissue with
oxygen and nutrients. This pulsatile component is typically weak
(0.02% to 20%) and needs to be amplified [13,14]. This waveform
constitutes the photoplethysmogram that is used in PPG sensors
and pulse oximeters. Figure 2-a shows a schematic of the different
components in the collected signal. In addition to the cardiac cycle
pulsations, there are other low frequency waveforms that can be
detected in the reflectance signal such as the respiratory cycle and
some vascular auto-regulation processes [15]. The remainder of
the collected signal is a non-pulsatile DC component carrying
information about surrounding tissue and the resting blood
volume which has a venous and arterial portion. Figure 2-b shows
the spectrum of a typical reflectance signal collected in vivo with the
system described herein prior to the AC amplification. Note that
since the DC component is much higher than all the AC
components it has been removed in this graph to better visualize
the AC peaks as a function of frequency.
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Current PPG sensors do not benefit from the information
contained in the DC component except for the sole purpose of
normalizing the AC signal to account for light coupling, source
intensity and other background noise signals. These sensors
provide information about the arterial portion of the vascular
network. Contrary to PPG sensors, NIRS systems utilize the
totality of the reflectance signal to measure concentration changes
in the different forms of hemoglobin (oxy-, deoxy-, met- and
carboxy-hemoglobin) and other confounder chromophores. How-
ever, in most NIRS systems, little attention is given to the pulsatile
signal, and the reflectance is used to measure a single value for
hemoglobin concentration representing the tissue oxygenation
level that is affected by both arterial and venous changes [16].
Some of these NIRS systems employ the pulsatile wave to assess
changes in the arterial blood component. To the knowledge of the
authors, no NIRS system has successfully separated the venous
contribution from the arterial components. As mentioned,
separating these two quantities (AC and DC) allows for the
quantification of tissue oxygen consumption. This can be used to
study the metabolic activity and relate it to tissue stress. Low
arterial oxygen levels indicate a deficiency in oxygen supply to the
tissue. On the other hand, low levels of venous oxygenation
indicate a high consumption rate (low perfusion levels) due to
extraction of oxygen by the tissue. These two levels coupled with a
relative perfusion measurement can be used to detect hemody-
namic complications and identify potential causes. The sensor
presented in this paper aims to simultaneously measure venous
oxygen saturation, arterial oxygen saturation, and perfusion levels
to provide physicians with a more complete picture of graft
hemodynamics in order to assess graft function intra- and post-
operatively.
The current standards for monitoring tissue perfusion levels are
laser Doppler flowmetry (LDF), transit-time ultrasound and
thermal diffusion [17–19]. Although these techniques have been
shown to be reliable in measuring perfusion changes, they lack any
sensitivity to blood oxygen levels. Thus, optical spectroscopy offers
a significant advantage over these techniques because of the
dependence of the hemoglobin extinction spectrum on its
oxygenation state [20]. Multiple groups have shown the efficacy
of NIRS in monitoring hepatic hemodynamics [21,22]. In this
paper, we report the first in vivo testing of a wireless optical sensing
system to monitor venous and arterial oxygenation coupled with
perfusion changes in liver tissue. This device is a first step toward a
fully implantable sensor for graft monitoring.
Figure 1. Schematic of the envisioned wireless sensor implanted on the liver.
doi:10.1371/journal.pone.0102396.g001
Figure 2. Typical PPG signal. a- Schematic of the collected reflectance signal (Note that the various signal components are not drawn to scale to
allow easy visualization). b- Spectrum of the reflectance signal collected with our sensor prior to amplification and with the DC signal omitted.
doi:10.1371/journal.pone.0102396.g002
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Materials and Methods
A. Instrumentation
The system developed for these studies consists of three sensors.
Two of the sensors are equipped with vascular probes to monitor
the vessels supplying blood to the liver, the hepatic artery (HA) and
the portal vein (PV). The third probe was used to monitor changes
in the hepatic parenchymal tissue. The HA and PV probes served
as reference measurements and are not required for the final
application since the measurements and calculations can be
performed with the parenchymal probe alone. In addition,
vascular probes are not favored by surgeons due to the
complications they can cause by disturbing blood flow or injuring
blood vessels during removal. The system consists of four printed
circuit boards, three of which are identical sensor interface boards
each having the full functionality of a sensor including three
programmable amplitude, time-multiplexed LED drives, and
synchronized detector signal amplification, dark current subtrac-
tion, filtering, and digitization. The fourth board includes the
microcontroller unit that communicates with and controls the
three sensors via the sensor interface boards. The microcontroller
also communicates wirelessly with a relay unit connected to a
laptop computer. The computer sends the acquisition parameters,
provides the visual interface, and allows further data analysis and
storage. The computer graphical user interface was developed in
Python to control the sensors, and allow the user to visualize the
data in real time. All electronics and a rechargeable lithium-ion
battery (BatterySpace.com, part# CU-MM184) were encapsulat-
ed in a custom plastic box (90.17680.00662.23 mm3) built using a
3D printer and coated with polydimethylsiloxane (PDMS). The
three probes were constructed using multi-wavelength LEDs
(Epitex L660/735/805/940-40B42) and a silicone photodetector
(Hamamatsu S2833-01) soldered to a custom printed circuit
board. Note that these LEDs contain four wavelengths in a single
package; however only three wavelengths (735, 805, and 940 nm)
were used in our sensors. The probes were also coated with PDMS
to avoid any leakage to the electronics. The source to detector
separation was set to 4 mm edge to edge (,8.7 mm center to
center) [8]. Although perfusion and oxygenation information can
be obtained using only two wavelengths, we added a third
wavelength to be able to account for artifacts on the signal such as
motion and other confounding chromophores. This feature was
not used in the processing of the data presented herein since these
studies were performed in a controlled environment. More details
about the probes’ geometry and the system design can be found in
the supporting information (Figure S1). Figure S2 in the
supporting information shows a picture of the system.
B. Data processing
Each of the sensors extracts an AC signal from the collected
diffuse reflectance (band-pass f3dB ,0.7 and 24.7 Hz) and
amplifies it by a gain specified by the user (1 to 96 X). Both the
DC and AC signals are transmitted to the data acquisition relay
unit and saved on a computer for further processing.
The signal processing used to extract oxygenation levels can be
divided in three parts. First, the normalized pulsatile signal (AC/
DC) on two of the wavelengths was used to measure the
oxygenation of the pulsatile blood flow similar to pulse oximetry.
This measurement tracks the oxygenation of the hepatic blood
supply. Second, the DC signal was processed similar to NIRS
signals which track tissue oxygen saturation. Both venous and
arterial blood contribute to tissue oxygenation. Last, the venous
oxygen saturation was extracted from the tissue oxygenation levels
using the already calculated arterial oxygenation. These three
steps are explained in more details in the following three sections.
AC processing. Fourier processing was used to measure the
amplitude of the pulsatile wave. The Fast Fourier Transform
(FFT) was calculated for 25 s data intervals using software
developed in MATLAB (Mathworks, Inc.). The software detects
the frequency peak that corresponds to the cardiac cycle and uses
it as the amplitude of the AC signal. The frequency of that peak
was used to measure the heart rate in beats per minute (60*fpeak).
Using the AC amplitude at the 735 and 940 nm wavelengths,
we calculated the modulation ratio R that is typically used in pulse
oximeters to assess oxygen saturation. This quantity requires a
calibration curve to produce quantitative oxygen saturation
results. To calibrate our sensor we fit the data to a calibration
model in the form shown in equation 1-b. Although the fitting
parameters (a, b, c, and d) can be estimated theoretically, previous
work has shown that the practical calibration curve is different
from the theory that is simplified and does not account for the
effects of scattering [23]. However, the general form of the
equation still holds.
R~
AC735=DC735
AC940=DC940
ð1 aÞ
SO2~
a:Rzb
c:Rzd
ð1 bÞ
The quantity (R) is a measure of the ratio of absorbance at the red
and NIR wavelengths of the pulsatile perfusion. Due to the
compliance of the tissue, blood flow loses its pulsation on the
venous side. Thus R is used to follow the changes in the oxygen
supply (i.e. arteries and the arterial side of the capillary network).
DC processing. The DC signals were processed using the
typical equations employed for NIRS signals [24]. The pathlength
factor was estimated using the theoretical equation reported by
Boas et al. [24]. These equations are used to derive the change in
concentration of oxyhemoglobin, deoxyhemoglobin, and total
hemoglobin (DHbO2, DHb, and DHbT respectively). The change
in total hemoglobin concentration (DHbT) tracks perfusion. To
obtain a measure of the change in oxygenation, we used the
hemoglobin oxygenation index (DHbD=DHbO22DHb) [25].
During perfusion changes, DHbO2 and DHb vary similarly and
the difference (DHbD) remains unaltered. However, for oxygen-
ation changes, DHbO2 and DHb vary in opposite directions
leading to a change in the hemoglobin oxygenation index (DHbD).
Venous oxygenation. The values calculated using the DC
levels as described above represent tissue oxygenation which may
be affected by either changes in oxygen supply (arterial side) or in
oxygen consumption (venous side). It is of paramount importance
to separate the two contributions to be able to possibly diagnose
the cause of complications when they occur. Most previous reports
employing NIRS measured, or assumed a constant percent
contribution of, venous and arterial components to the collected
signal [16,26]. This ratio is different for various types of tissue and
probe geometries. If this ratio is determined it can be used to
extract the venous signal contribution to the DC levels. To
accomplish that we used Multiple Linear Regression (MLR), and
the measured venous oxygenation was fit to the linear combination
of the DC measured changes (DHbD) and the oxygen saturation of
the supply (equation 2). Figure 3 shows a flow chart of the signal
processing.
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SvO2~a:DCzb:SO2zc ð2Þ
C. Animal study protocol
The animal study was performed on two swine (a 21 kg male
and a 27 kg female). Prior to anesthesia, the animals were
premedicated with Telazol (5–10 mg/kg intramuscularly, im) and
the analgesic Buprenorphine (0.01–0.05 mg/kg, im). To induce
anesthesia, the animals were administered 3–4% Isoflurane in
oxygen at 3 L/min via a face mask. An endotracheal tube was
inserted into the trachea, secured in place and connected to a
mechanical ventilator (8–12 BPM and tidal volume of 5–10 mL/
lb). Isoflurane (0.5–4%) was administered in oxygen to maintain
anesthesia. A laparotomy was performed to expose the liver and its
vasculature. Transit-time ultrasound probes were placed on the
hepatic artery (Transonic Systems, cat# MA4PSB) and the portal
vein (Transonic Systems, cat# MA10PSB) to monitor flow
changes. An oxygenation catheter was placed in the aorta via
the iliac artery (Edwards Lifesciences, cat# XA3820HKCDC) and
connected to a Vigilance Monitor (Edwards Lifesciences). Another
oxygenation catheter was placed in the inferior vena cava at the
level of the hepatic veins to monitor venous oxygenation changes.
Two laser Doppler flowmeter probes were placed on the
parenchyma to monitor tissue perfusion changes. A catheter was
placed in the femoral artery to monitor arterial pressure.
Throughout the experiments, vital signs (body temperature,
SpO2, heart rate, blood pressure, etc.) were monitored closely
and recorded. All reference equipment was connected to a custom
built data acquisition system and saved for further processing.
Similarly, three probes from the optical telemetry system were
placed on the HA, PV, and the liver parenchyma. All probes were
secured using 5/0 polypropylene sutures. Note that the HA and
PV probes were placed for reference; however, no vascular probes
will be required for the final application. Vascular occluders
(Harvard Apparatus, part.# PY2 62-0111, -0113, and -0117) were
placed on the HA and PV to be able to alter hepatic flow and
perfusion. Hypoxia was induced by inhalation of low oxygen
content mixtures. The wireless sensor electronic unit was placed
outside the body next to the animal on the surgical table and
tethered to the probes. The relay unit was connected to a laptop
placed approximately 4 feet from the surgical table. Data were
collected intermittently prior, during, and after any flow or
oxygenation perturbation. At the end of the experiment, while still
anesthetized, the animal was euthanized with a barbiturate
derivative solution administered intravenously (80–120 mg/kg).
Finally, livers were extracted and weighed (465 and 525 g for the
21 and 27 kg animals respectively) to convert the flow measure-
ments (mL/min) into an average tissue perfusion measure (mL/
min/g of tissue). All studies were performed under an animal use
protocol (AUP #2010-257) approved by the Institutional Animal
Care and Use Committee at Texas A&M University.
D. Reference Measurements
The liver has a complex vasculature that is supplied by two
different vessels: the hepatic artery (HA) and the portal vein (PV).
The HA supplies approximately 25% of nutrients and total blood
flow but it is rich in oxygen and delivers approximately 75% of the
total liver oxygen supply. The PV is part of the venous system but
supplies blood to the liver. The portal venous blood is rich in
nutrients but relatively poor in oxygen, and it supplies roughly
75% of liver nutrients along with 25% of its oxygen. Thus, the
supply oxygenation in the liver tissue is not that of the artery alone,
but it is the addition of the contribution of the PV and the HA. In
the remainder of this manuscript we will refer to this quantity as
the mixed oxygen saturation (MOS) as defined in equation 3. Due
to the limited exposed space on the PV (few centimeters) and the
required flow probes and vascular occluders placed on that vessel,
we could not insert a catheter into the PV to monitor its
oxygenation. We assumed it to be equal to the non-hepatic venous
oxygenation for the purpose of our calculations.
MOS(%)~
FlowHA:SaO2zFlowPV :SvO2
Flowtotal
ð3Þ
Note that MOS represents the oxygen supply to the liver and will
be compared to the oxygen saturation predicted by the pulsatile
AC signal as discussed earlier (Figure 3).
Similarly, total hepatic flow is the sum of PV flow and HA flow.
In addition to the Laser Doppler Perfusion monitor, we used the
total flow as measured by two Transit-Time vascular flow
monitors to track tissue perfusion as described by equation (4)
below:
Flowtotal~FlowHAzFlowPVa Tissue Perfusion ð4Þ
Two different data collection procedures were used on the two
animals. For the first study, we induced hypoxia without imposing
any change in the hepatic flow to test the ability of the sensor to
track oxygenation changes. The second study began with four
consecutive hepatic artery occlusions, followed by three portal vein
occlusions. These occlusions were performed at normal systemic
oxygenation levels. Hypoxia was induced afterwards, and vascular
occlusions (HA and PV) were performed again at low systemic
oxygenation levels. All occlusions were brief (less than 1 minute for
full occlusion) and were performed in gradual steps. Although the
inhaled oxygen level was not changed during occlusions, the
hepatic oxygen saturation is expected to be altered due to an
increased hepatic oxygen extraction ratio and a change in the
relative flow (see the MOS equation above) of the HA (high
oxygen content) and PV (low oxygen content).
Results and Discussion
To verify that the pulsatile signal is tracking the cardiac cycle,
we looked at the cardiac cycle peak detected by our system and
compared it to the heart rate measured by the arterial pressure
catheter. This was performed on data from both animals and the
Figure 3. Flow chart of the signal processing. This was employed
to compute the oxygen saturation at the arterial and venous side along
with perfusion changes from the measured AC and DC signals.
doi:10.1371/journal.pone.0102396.g003
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detected heart rate was accurate with a Root Mean Square Error
(RMSE) of 3.9 bpm (0.065 Hz). Some of this error is due to the
difference in the integration time between the telemetry sensor
(25 s) and the pressure catheter (2 s). Figure 4 shows the heart rate
throughout the study as measured from the arterial pressure
catheter and the FFT of the PPG signal measured with the
telemetry sensor.
A. Oxygenation data
To track oxygenation changes, the hemoglobin oxygenation
index (DHbD) was computed, as obtained from the measured DC
levels, which, as discussed in the Materials and Methods section, is
a measure of tissue oxygenation affected by both arterial and
venous oxygen saturation levels. This level is compared to both
oxygen supply (MOS) and venous oxygenation (SvO2) from the
two different studies as shown in Figure 5. The raw data from the
oximetry catheters are shown in the supporting information
(Figure S5). As described earlier, for the first study (Figure 5-a) we
induced hypoxia and we did not alter perfusion. However, in the
second study (Figure 5-b) we had multiple occlusions of the HA
and PV at various levels of oxygen saturation during hypoxia.
Vascular occlusions have been shown to alter tissue perfusion and
oxygenation in liver tissue [21]. In the following figures, hypoxia
periods are indicated by a dark grey box on the upper horizontal
axis. Note that the recovery period from hypoxia is also included
in the grey boxed region. Vertical white lines indicate segments
where one or more hepatic artery occlusions were performed while
horizontal white lines indicate where one or more portal vein
occlusions were performed. The occlusion periods include multiple
occlusions and baseline readings in between.
Figure 5 indicates that the measured hemoglobin oxygenation
index is tracking oxygenation changes. This measure was obtained
from the collected DC signal that is probing both the HA/PV
supply and the post-hepatic venous components. To verify that
this measure contains oxygenation information about both supply
and hepatic venous blood we correlated the measurements to the
reference data obtained from the oxygenation catheters and flow
meters. Although DHbD correlated well with both supply and
venous oxygenation (data shown in supporting information, Figure
S6), it correlated best with a combination of the two using multiple
linear regression (MLR) analysis described by equation 5. The
coefficient of determination (R2) was 0.99 for study 1 (no vascular
occlusions) and 0.80 for study 2 (vascular occlusions at multiple
levels of oxygenation) respectively. This corresponds to a root
mean square error (RMSE) of 1.39% and 3.93% respectively.
DHbD~a:MOSzb:SvO2zc ð5Þ
Having the calibration coefficients (a, b, and c) from the MLR, the
mixed oxygen saturation (MOS) measured by the gold standards,
and the hemoglobin oxygenation index (DHbD) measured by the
telemetry system, equation 5 was used to compute venous oxygen
saturation (SvO2). Figure 6 shows the predicted venous oxygen-
ation and the measured oxygenation by the venous catheter as a
function of time. Note that in study 2, occlusions are performed on
the hepatic artery and are always seen as a decrease in the
measured venous oxygenation by our probe. However, this
decrease is not detected by the venous catheter during the first
three occlusions because the catheter was measuring hemoglobin
oxygen saturation in the vena cava rather than the hepatic veins.
Thus, the first three occlusions performed on the hepatic artery
caused a decrease in the hepatic venous oxygen saturation as
shown by our probe but did not have a substantial effect on the
systemic venous oxygenation, where the venous catheter is
measuring, since the HA flow is relatively low (7% of total cardiac
output) compared to the portal vein flow (22% of total cardiac
output).
The data from both experiments are shown on the scatter plot
of figure 7. Note that the data from study 2 have a higher RMSE
(3.93%) compared to study 1 (1.39%). This increase is mainly due
to the occlusions performed in that study, and part of this
perceived error is from the reference measurements, and not our
system, because it was probing central venous oxygenation and not
the hepatic vein.
The data shown in Figures 4 and 5 use the supply oxygen
saturation levels obtained from the catheters to extract the venous
oxygenation from the DC levels. However, as described earlier, we
wanted to determine the supply oxygenation levels from the
pulsatile signal and avoid using any additional reference measure-
ments. To do so, the modulation ratio (R) was calculated, and
measurements were calibrated as discussed in the materials and
methods section. The data from each experiment were calibrated
separately. These measurements were compared to the Mixed
Oxygen Saturation (MOS) described earlier. Figure 8 shows the
measured MOS and the reference data from the catheters and the
flowmeters computed using equation 3. The modulation ratio was
able to predict the MOS except when the oxygen saturation
dropped below 75%. This is a known problem of pulse oximeters
and is mainly due to the high attenuation of the red wavelength
(735 nm) for low oxygenation levels. If needed, this issue can be
resolved by optimizing the sensor design (illumination wavelength,
amplification, etc.) to operate for low oxygen saturation levels [27].
During study 2, the oxygen saturation during vascular occlusions
dropped to as low as 56%, and the sensor was still able to measure
it accurately. We believe this is due to the decreased absorbance as
a result of the perfusion decrease that allowed the red wavelength
(735 nm) to still be measured accurately.
For oxygenation levels above 72% (for normal perfusion levels)
and 55% (for low perfusion levels) the calculated modulation ratio
from the pulsatile signal was able to predict oxygenation changes
with an RMSE of 2.19% and 2.82% for study 1 and 2 respectively.
Figure 9 shows the corresponding scatter plot.
These predicted MOS levels can be used with equation 5 to
predict venous oxygenation SvO2 without the need for a reference
measurement. Because the pulsatile signal could not predict data
for very low oxygen saturations, we tested this concept on all other
Figure 4. Heart rate measurements. Data from the arterial pressure
catheter (grey) and the telemetry sensor (black).
doi:10.1371/journal.pone.0102396.g004
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parts of the data, and we obtained the measurements shown in
Figure 10. For study 1, we were able to measure venous oxygen
saturation with an RMSE of 1.17% (R2= 0.986) while for study
2 the RMSE was higher at 3.44% (R2= 0.1). This increased
prediction error is mainly due to the changes measured during HA
occlusions that are not reflected in the central venous oximetry
catheter measurements. However, we believe that these changes
likely reflect variations in the hepatic venous oxygenation.
B. Perfusion data
One of the important features of the presented sensor is the
ability to track perfusion and oxygenation changes simultaneously.
To track perfusion changes, we measured the change in tissue total
hemoglobin concentration (DHbT) as described in the Materials
and Methods sections. After analyzing the laser Doppler flowmetry
(LDF) data from the commercial system, we found that the LDF
signal correlated with changes in HA flow but not PV nor total
flow (R-square = 0.8, 0.1, and 0.5 respectively) measured by
vascular transit-time ultrasonic flowmeters. These data are shown
in detail in Figures S3 & S4. We believe that the LDF was probing
a branch of the HA and was not tracking tissue perfusion. Because
the LDF measurements reflected the HA flow and not tissue
perfusion, they were not used as a reference for parenchymal
perfusion. Instead, the total hepatic flow measured by the addition
of the signal from two transit-time ultrasound flowmeters (HA &
PV) was used as the reference for parenchymal perfusion
measurements.
Figure 11-a shows the changes in hemoglobin concentration
measured by the optical telemetry sensor and the total hepatic flow
measured by the transit-time ultrasonic flowmeters. The two
Figure 5. Oxygenation changes as measured by the sensor and the oximetry catheters. Hemoglobin oxygenation index (right axis)
measured by the optical telemetry system versus venous and mixed oxygen saturation (left axis) for study 1 (left panel) and 2 (right panel). Venous
oxygenation is measured by the oximetry catheter placed in the vena cava while the supply oxygenation is the weighted average of the HA and PV
oxygenation described by equation 3.
doi:10.1371/journal.pone.0102396.g005
Figure 6. Venous oxygen saturation. Data from the telemetry sensor (black dots) and the central venous catheter (grey line) for study 1 (left) and
2 (right).
doi:10.1371/journal.pone.0102396.g006
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quantities correlate with high accuracy in the first 70 minutes of
the study (t = 150–220 min) during which four HA occlusions were
performed. After the first PV occlusion (t = 220 min), the signal
from the optical telemetry sensor showed a slow decreasing trend
in perfusion while the transit-time flowmeter showed an increase.
This is due to the fact that the telemetry sensor is measuring tissue
perfusion directly by looking at the tissue hemoglobin content
while the ultrasonic transit-time flowmeter is measuring vascular
flow changes. This discrepancy between the two can be due to a
systemic response causing vasoconstriction that results in a
decrease in microvasculature perfusion while increasing the blood
flow in the central vasculature. Such a response can be triggered
by a decrease in blood pressure. To verify this theory, we looked at
the change in the Mean Arterial Pressure (MAP) shown in
Figure 11-b. During the period of increase in the Transit-Time
flowmeter signal, the MAP increased from 52 mmHg to more
than 70 mmHg. We believe this event was triggered by the first
portal venous occlusion that caused a decrease in venous return to
the heart thereby causing a decrease in blood pressure to around
30 mmHg. This decrease in pressure is not seen during the first
four occlusion events (HA occlusions) since the HA flow (350 mL/
min in humans) is much lower than the PV flow (1100 mL/min,
,22% of total cardiac output) [28]. In general, vasoconstriction is
associated with an increase in MAP which supports our proposed
explanation [28]. In addition, we looked at the telemetry sensor
data from the hepatic artery probe, and they showed a similar
increasing trend as measured by the Transit-Time flowmeter
(Figure S7). This is an advantage of the employed technique since
perfusion measurements are desired. Flow readings are usually
used as an estimate of perfusion trends; however, in addition to
perfusion, these measurements are affected by changes in blood
pressure. Spectroscopy based techniques measure the real
hemoglobin content in tissue which is essential to know the
availability of nutrients and oxygen to cells.
Figure 7. Scatter plot of the predicted (telemetry) versus
measured (catheter) venous oxygen saturation for both
studies (1: black & 2: grey).
doi:10.1371/journal.pone.0102396.g007
Figure 8. Mixed oxygen supply (MOS) measured by the telemetry sensor (black dots) and the reference equipment (grey line) for
both studies (1: left, & 2: right).
doi:10.1371/journal.pone.0102396.g008
Figure 9. Scatter plot of the predicted vs. measured MOS for
study 1 (black) and 2 (grey).
doi:10.1371/journal.pone.0102396.g009
Wireless Monitoring of Liver Hemodynamics In Vivo
PLOS ONE | www.plosone.org 7 July 2014 | Volume 9 | Issue 7 | e102396
To assess the accuracy of the perfusion measurements, we
compared the readings from the telemetry sensor and the Transit-
Time flowmeter prior to the increase in blood pressure (first 4
occlusions). The telemetry sensor was able to resolve perfusion
changes with an RMSE of 0.135 mL/min/g of tissue (70.87 mL/
min) as shown in Figure 12. Note that the standard deviation of
the Transit-Time flowmeter measurements (0.09 mL/min/g of
tissue u 47.6 mL/min) during the first baseline collection
(t = 148–155 min) is on the same order as the RMSE of the
telemetry sensor.
Discussion
The oxygenation measurements obtained by the telemetry
sensor agreed for the most part with the reference oxygen
saturation measurements acquired by the vascular catheters.
Specifically, the pulse oximetery signal was shown to track the
defined quantity MOS which is a function of the flow and
oxygenation of the HA and PV. The hepatic tissue supply
oxygenation was measured with an RMSE of 2.82% for the range
72–100%. We were able to resolve venous oxygenation changes
with an RMSE of 1.39%. This resolution went up to 3.93% when
vascular occlusions were performed simultaneously with the
hypoxia. Finally, we were able to measure perfusion changes with
Figure 10. Predicted venous oxygen saturation by combining the DC NIRS measurements with the AC pulse oximetry
measurements. Note that the missing values correspond to the periods where MOS dropped below 72% and, because of the previously reported
problem with signal from the red wavelength, could not get reliable pulse oximetry measurements. Study 1 & 2 are shown in left & right panel
respectively.
doi:10.1371/journal.pone.0102396.g010
Figure 11. Hepatic flow changes. (Left) Changes in total hemoglobin concentration (DHbT, black dots) in hepatic tissue versus total hepatic flow
measured by the addition of the HA and PV Transit-Time flowmeters’ measurements (grey line). (Right) Total hepatic flow (grey) and mean arterial
pressure (black) trends show that the increase in flow after t = 200 min is accompanied by an increase in the arterial pressure suggesting that a
systemic response is responsible for that increase.
doi:10.1371/journal.pone.0102396.g011
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a resolution of 0.135 mL/min/g of tissue in the range of 1.5 to
3.0 mL/min/g. This resolution was similar to the variation of the
baseline measurements by the reference flowmeters.
The main discrepancy between the oxygenation measurements
obtained by the telemetry sensor and the reference oxygen
saturation measurements acquired by the vascular catheters
occurred during HA occlusions where the telemetry sensor
showed a decrease in the venous oxygen saturation while the
central venous catheter did not show any change. We believe that
the short duration of occlusions on the HA caused a local drop in
the intrahepatic venous oxygenation which was not reflected in the
systemic data. Note that some reports have stated concerns about
using NIRS to estimate oxygenation changes during changes in
tissue hemoglobin content [29] while others use this method to
assess desaturation during occlusions [30]. This makes it more
important to always report the total hemoglobin concentration
(HbT) along with the oxygenation level so that the user is aware of
the possibility of low accuracy in oxygenation measurements
during low perfusion periods.
During vascular occlusions, the measured hemoglobin concen-
tration changes correlated with the hepatic flow (R2,0.78).
During these occlusions, HbT levels decreased, while Hb
concentration increased and HbO2 concentration decreased. This
agrees with previously reported findings by El-Desoky et al. that
measured hemoglobin changes in porcine hepatic tissue using a
commercial bench-top NIRS system [21]. The RMSE in tracking
tissue perfusion was found to be 0.13 mL/min/g. We believe that
part of this error is caused by the comparison of direct perfusion
measurements from the telemetry system to flow levels measured
by the reference vascular flowmeters. Soft tissue acts as a capacitor
and quick changes seen in the vascular flow can sometimes be
delayed and filtered by the tissue. Note that the described sensor
measures changes in tissue hemoglobin content and not perfusion.
These two quantities may differ in some cases such as during
venous congestion. However, coupling this measurement with the
oxygenation data gives the medical care provider the information
needed to detect these cases. For example, the increase in tissue
hemoglobin content during venous congestion is accompanied by
a drop in tissue oxygen saturation which indicates pooling of
venous blood within tissue.
The results presented in this manuscript are a first realization of
a wireless optical sensor for monitoring liver tissue hemodynamics.
We believe this technology can lead to a fully implantable device
to monitor patients in the 14 days period following transplant.
Over 55% of rejections take place in these two weeks [3].
Following that period, the device can be explanted in a minimally
invasive surgery. The device can be implanted either intraperito-
neally and fixed on liver tissue, or submdermally with a probe
linking the main unit to hepatic tissue. Many challenges need to be
addressed before this prototype can be translated into a viable
clinical product. One of these challenges is the power source. As
mentioned earlier, the current prototype runs on a lithium-ion
battery. The current battery is capable of running a single sensor
for almost 14 days (13.89 days) with one reading (30 seconds of
data) every 5 minutes. Lowering the power consumption of the
device and/or finding alternative ways to power it, such as
inductive coupling, can reduce the size of the battery and lead to a
smaller implant. Another challenge is the coating of the device.
The encapsulation of the implanted sensor due to innate host
response can lead to difficulties in the sensor removal which may
lead to injury. Similar to other implanted electronic devices (i.e.
pacemaker), the sensor has to be placed in a sealed enclosure such
as a titanium case to protect the electronics. The casing can then
be coated with a ‘‘biocompatible’’ polymer if needed such as
polyethylene glycol. Finally, motion artifacts and being able to
account for those is another challenge. Our current design
implements a set of band-pass filters that allow us to filter out
the majority of low frequency (,0.6 Hz) artifacts, such as
respiratory motion and other slow processes, and high frequency
(.15 Hz) noise. In addition, we have developed multiple
processing techniques to use the additional wavelengths to account
for artifacts due to motion and other confounding variables
[31,32].
Conclusions
In this paper, NIRS combined with photoplethysmography
(PPG) was used to demonstrate, for the first time, simultaneous, in
vivo wireless, measurements of hepatic perfusion, and oxygenation
levels. The combination of these two techniques does not require
any additional hardware to the traditional PPG sensors and offers
Figure 12. Hepatic flow changes prior to the increase in blood pressure. (Left) Total hemoglobin concentration (DHbT) and flow changes.
(Right) Scatter plot of measured hemoglobin concentration change (DHbT) vs. tissue perfusion (flow normalized by liver weight).
doi:10.1371/journal.pone.0102396.g012
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the advantage of measuring simultaneously oxygen supply (MOS)
and consumption (SvO2). The ability to measure these parameters
simultaneously ultimately gives physicians a more complete picture
of the graft hemodynamics providing some confidence that this
approach has potential for assessing the organ function in real time
and detecting complications at an early stage.
Supporting Information
Figure S1 CAD drawings of the probes. a-Suture holders
for the parenchymal, HA, and PV probes (left to right). b & c-
CAD drawing of a parenchymal and a vascular probe respectively.
(TIF)
Figure S2 The optical sensors used in the studies. (Left)
CAD drawing of the electronics box showing the PCBs inside.
(Right) Picture of the telemetry system showing the sensor, probes,
and data acquisition software.
(TIF)
Figure S3 Laser Doppler and transit time Doppler
perfusion and flow measurements. Scatter plots of the
Laser Doppler data versus HA flow (left), PV flow (middle), and
total hepatic flow (right). The data shows that the LD data
correlates best with the HA flow suggesting that the system was
probing a branch of the HA.
(TIF)
Figure S4 Reference flow measurements. Data from the
transit time flowmeters (left axis) and Laser Doppler flowmeter
(right axis). The time segments highlighted in red correspond to
HA occlusion studies while the blue segments correspond to PV
occlusion studies.
(TIF)
Figure S5 Oximetry catheters’ data. Arterial and venous
oxygen saturation from experiment 1 (left) and 2 (right).
(TIF)
Figure S6 Comparison of the measured hemoglobin
oxygenation index (DHbD) to the arterial and venous
oxygen saturation levels. (Left) Correlation between DHbD
and the measured oxygenation levels. (Right) Calibrated DHbD
can predict SvO2 with a higher degree of confidence (R2= 0.99)
when using a multiple linear regression taking account for both
supply and venous oxygenation.
(TIF)
Figure S7 Total hemoglobin concentration (DHbT) as
measured by the hepatic artery probe.
(TIF)
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